Casper Steenholdt (C Steenholdt)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

Journal of gastroenterology and hepatology

Alimentary pharmacology & therapeutics

BMJ open gastroenterology

Frontline gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen, Ella Sk Widigson, Charlotte Kloft, Rolf Anton Klaasen, Jørn Brynskov
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease. Journal of gastroenterology and hepatology 39 (6) (2024)
Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics (2024)
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen, Ella Sk Widigson, Charlotte Kloft, Rolf Anton Klaasen, Jørn Brynskov
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease. Journal of gastroenterology and hepatology (2024)
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen, Ella Sk Widigson, Charlotte Kloft, Rolf Anton Klaasen, Jørn Brynskov
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease. Journal of gastroenterology and hepatology 39 (6) (2024)
Mohamed Attauabi, Casper Steenholdt, Anja Poulsen, John Mark Gubatan, Burisch J, Ole Haagen Nielsen, Jakob Benedict Seidelin
Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Casper Steenholdt, Lars Erik Kristensen, Jørn Brynskov
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to Tofacitinib. The American journal of gastroenterology 117 (1) (2022)
Alix Démaris, Ella S K Widigson, Johan F K F Ilvemark, Casper Steenholdt, Jakob B Seidelin, Wilhelm Huisinga, Robin Michelet, Linda B S Aulin, Charlotte Kloft
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review. Pharmaceutics 14 (10) (2022)
Casper Steenholdt, Lene Buhl Riis
Localised colonic AL amyloidosis: a rare manifestation of a rare disease. Frontline gastroenterology 14 (2) (2022)
Katrine Risager Christensen, Mark Andrew Ainsworth, Casper Steenholdt, Sine Buhl, Marie Skougaard, Jørn Brynskov, Tanja Schjødt Jørgensen, Lars Erik Kristensen
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics. Scandinavian journal of gastroenterology 57 (9) (2022)
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen, Jørn Brynskov
Trajectories of health-related quality of life and fatigue during vedolizumab therapy in inflammatory bowel disease. Journal of gastroenterology and hepatology (2022)
Katrine Risager Christensen, Mark Andrew Ainsworth, Marie Skougaard, Casper Steenholdt, Sine Buhl, Jørn Brynskov, Lars Erik Kristensen, Tanja Schjødt Jørgensen
Identifying and understanding disease burden in patients with inflammatory bowel disease. BMJ open gastroenterology 9 (1) (2022)
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen, Jørn Brynskov
Trajectories of health-related quality of life and fatigue during vedolizumab therapy in inflammatory bowel disease. Journal of gastroenterology and hepatology (2022)
Casper Steenholdt, Lene Buhl Riis
Localised colonic AL amyloidosis: a rare manifestation of a rare disease. Frontline gastroenterology 14 (2) (2022)
Ana-Marija Grišić, Maria Dorn-Rasmussen, Bella Ungar, Jørn Brynskov, Johan F K F Ilvemark, Nils Bolstad, David J Warren, Mark A Ainsworth, Wilhelm Huisinga, Shomron Ben-Horin, Charlotte Kloft, Casper Steenholdt
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease. United European gastroenterology journal 9 (1) (2021)
Ruben Due Lorentsen, Louise Laurberg Klarskov, Casper Steenholdt
Severe ulcerative oesophagitis caused by primary Epstein-Barr virus infection in an immunocompetent individual. BMJ open gastroenterology 8 (1) (2021)
Rikke B Holmstrøm, Ditte V Mogensen, Jørn Brynskov, Mark A Ainsworth, Jacob Nersting, Kjeld Schmiegelow, Casper Steenholdt
Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease. Digestive diseases and sciences 63 (6) (2018)
K Bendtzen, Casper Steenholdt
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Alimentary pharmacology & therapeutics 45 (5) (2017)